Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 1 May 2004, Vol. 103, No. 9, pp. 3287-3295.
Prepublished online as a Blood First Edition Paper on January 15, 2004; DOI 10.1182/blood-2003-07-2428.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-07-2428v1
103/9/3287    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carlo-Stella, C.
Right arrow Articles by Gianni, A. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carlo-Stella, C.
Right arrow Articles by Gianni, A. M
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted July 18, 2003
Accepted January 5, 2004

Use of Recombinant Human Growth Hormone (rhGH) plus Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) for the Mobilization and Collection of CD34+ Cells in Poor Mobilizers

Carmelo Carlo-Stella*, Massimo Di Nicola, Raffaella Milani, Anna Guidetti, Michele Magni, Marco Milanesi, Paolo Longoni, Paola Matteucci, Franca Formelli, Fernando Ravagnani, Paolo Corradini, and Alessandro M Gianni

Cristina Gandini Medical Oncology Unit, Istituto Nazionale Tumori, Milano, Italy; Chair of Medical Oncology, University of Milano, Milano, Italy
Cristina Gandini Medical Oncology Unit, Istituto Nazionale Tumori, Milano, Italy
Hematology and Bone Marrow Transplantation Unit, Istituto Nazionale Tumori, Milano, Italy
Department of Experimental Oncology, Istituto Nazionale Tumori, Milano, Italy
Division of Immunohematology and Transfusion Medicine, Istituto Nazionale Tumori, Milano, Italy
Hematology and Bone Marrow Transplantation Unit, Istituto Nazionale Tumori, Milano, Italy; Chair of Hematology, University of Milano, Milano, Italy

* Corresponding author; email: carmelo.carlostella{at}unimi.it.

The activity of recombinant human growth hormone (rhGH) in enhancing CD34+ cell mobilization elicited by chemotherapy plus granulocyte colony-stimulating factor (rhG-CSF) was evaluated in 16 hard-to-mobilize patients, i.e., those achieving a peak of circulating CD34+ cells <=10/µL, or a collection of CD34+ cells <=2 x 106/kg. Patients who had failed a first mobilization attempt with chemotherapy plus rhG-CSF (5 µg/kg/day) were re-mobilized with chemotherapy plus rhG-CSF and rhGH (100 µg/kg/day). As compared with rhG-CSF, the combined rhGH/rhG-CSF treatment induced significantly higher (P <=.05) median peak values for CD34+ cells/[mu]L (7 vs 29), CFCs/ml (2,154 vs 28,510), and LTC-IC/ml (25 vs 511). Following rhG-CSF and rhGH/rhG-CSF, the median yields of CD34+ cells per leukapheresis were 1.1 x 106/kg and 2.3 x 106/kg (P <=.008), respectively; the median total collection of CD34+ cells were 1.1 x 106/kg and 6 x 106/kg (P <=.008), respectively. No specific side effect could be ascribed to rhGH, except a transient hyperglycemia occurring in two patients. Reinfusion of rhGH/rhG-CSF-mobilized cells following myeloablative therapy resulted in prompt hematopoietic recovery. In conclusion, our data demonstrate that in poor mobilizers addition of rhGH to rhG-CSF allows to efficiently mobilize and collect CD34+ cells with maintained functional properties.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
A. A van der Klaauw, A. M Pereira, T. J Rabelink, E. P M Corssmit, A.-J. Zonneveld, H. Pijl, H. C de Boer, J. W A Smit, J. A Romijn, and E. J P de Koning
Recombinant human GH replacement increases CD34+ cells and improves endothelial function in adults with GH deficiency
Eur. J. Endocrinol., August 1, 2008; 159(2): 105 - 111.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. Focosi, R. E. Kast, S. Galimberti, and M. Petrini
Conditioning response to granulocyte colony-stimulating factor via the dipeptidyl peptidase IV-adenosine deaminase complex
J. Leukoc. Biol., August 1, 2008; 84(2): 331 - 337.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Papayannopoulou and D. T. Scadden
Stem-cell ecology and stem cells in motion
Blood, April 15, 2008; 111(8): 3923 - 3930.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
R. M. Lemoli and A. D'Addio
Hematopoietic stem cell mobilization
Haematologica, March 1, 2008; 93(3): 321 - 324.
[Full Text] [PDF]


Home page
BloodHome page
O. M. Pello, M. del Carmen Moreno-Ortiz, J. M. Rodriguez-Frade, L. Martinez-Munoz, D. Lucas, L. Gomez, P. Lucas, E. Samper, M. Aracil, C. Martinez-A, et al.
SOCS up-regulation mobilizes autologous stem cells through CXCR4 blockade
Blood, December 1, 2006; 108(12): 3928 - 3937.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020